Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Jiani Li, PhD
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-2025) Resistance Analyses from the Remdesivir Phase 2/3 CARAVAN Study in Pediatric and Neonatal Participants Hospitalized with COVID-19
Saturday, October 19, 2024
12:15 PM – 1:30 PM
US PT
(P-2030) Remdesivir and Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants
Saturday, October 19, 2024
12:15 PM – 1:30 PM
US PT